Cullinan Therapeutics Inc.
06/16/2026 | Press release | Distributed by Public on 06/16/2026 15:18
Proxy Results (Form 8-K)
Item 5.07 Submission of Matters to a Vote of Security Holders.
The Annual Meeting of Stockholders (the "Annual Meeting") of Cullinan Therapeutics, Inc. (the "Company") was held on June 16, 2026. The holders present voted on the three proposals presented at the Annual Meeting as follows.
Proposal One - Election of Directors
The Company's stockholders elected two Class III directors to the Company's Board of Directors for three-year terms or until his successor has been duly elected and qualified, or until his earlier death, resignation or removal, by the following votes:
|
Nominee |
Votes For |
Votes Withheld |
Broker Non-Votes |
|||
|
Nadim Ahmed |
37,519,241 |
12,116,759 |
4,126,430 |
|||
|
Stephen Webster |
36,963,086 |
12,672,914 |
4,126,430 |
Proposal Two - Ratification of Appointment of Independent Registered Accounting Firm
The Company's stockholders ratified the appointment of KPMG LLP as the Company's independent registered accounting firm for the fiscal year ending December 31, 2026 by the following votes:
|
Votes For |
Votes Against |
Abstentions |
Broker Non-Votes |
|||
|
53,722,477 |
36,815 |
3,138 |
0 |
Proposal Three - Advisory Vote on Executive Compensation
The Company's stockholders approved the advisory vote on the compensation of the Company's named executive officers by the following votes:
|
Votes For |
Votes Against |
Abstentions |
Broker Non-Votes |
|||
|
48,536,734 |
1,092,209 |
7,057 |
4,126,430 |
Cullinan Therapeutics Inc. published this content on June 16, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on June 16, 2026 at 21:18 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]